Significant up-regulation of HIF-1α expression has been demonstrated in glioma cells and clinical specimens [7, 8], and there is accumulating evidence that down-regulation of HIF-1α can inhibit tumor angiogenesis and cell invasion [2, 9]. The gene discussed is HIF1A; the disease is central nervous system cancer.